A study led by researchers from the Hospital Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Centre, has identified CD70 as a mark...
A study co-led by Sònia Guedan, head of the IDIBAPS Cellular immunotherapies for cancer group, has shown in various animal cancer models that the...
Professionals from Hospital Clínic-IDIBAPS are leading two projects in medical technology innovation and two in advanced drug and therapy developme...
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Can...
Researchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy com...
The objective is to deepen the molecular and genomic understanding of various diseases and facilitate patient translation. The program has been fun...
A study led by researchers from the Clínic-IDIBAPS paves the way for the design and optimization of CAR T-cell therapy for greater effectiveness in...
The goal of the KAIROS project, driven by 6 Clínic-IDIBAPS research groups, will be to enhance molecular and genetic knowledge about various diseas...
The IDIBAPS Board of Governors has approved the creation of a new research group. The decision follows the scientific evaluation of the researchers...
The researchers’ goal is to develop a method to reverse the exhaustion that affects T-cells during protracted battles with tumor cells, preventing...
